Barbara Gayle Duncan Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Barbara Gayle Duncan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is a Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).

Address: C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK 10011 NY

Companies in which Barbara Gayle Duncan is an Insider

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barbara Gayle Duncan: Chief Financial Officer
Holdings: 17,264 shares
Current Value: $1,960,672
Latest Transaction: Jan 07 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Barbara Gayle Duncan

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS176.4914124,88417,26417.4 K to 17.3 K (-0.81 %)
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM31.901,00031,90014,875
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29805,192
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS158.3550079,17517,40517.9 K to 17.4 K (-2.79 %)
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS154.4550077,22517,90518.4 K to 17.9 K (-2.72 %)
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM31.901,00031,90018,40517.4 K to 18.4 K (+5.75 %)
Jan 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298017,40516.1 K to 17.4 K (+8.06 %)

View all Barbara Gayle Duncan insider transactions.